Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07021222

Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaFoot)

Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Istituto Ortopedico Rizzoli · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a no-profit, multicentre, national, clinical trial for the prevention of the complications of the diabetic foot in two populations of patients with diabetes mellitus type-2.

Detailed description

This is a no-profit, multicentre, national, clinical trial for the prevention of the complications of the diabetic foot in two populations of patients with diabetes mellitus type-2. A first population has no previous history of foot ulceration, but has a moderate ulcerative risk (grade 2); a second population is affected by diabetic foot, had foot ulcers (grade 3), but these must have been resolved from at least six months. One centre provides thorough biomechanical and functional analyses also based on modern Computed Tomography in weight-bearing; another centre performs state-of-the-art clinical assessments and metabolic analyses; the third centre performs the latter, together with advanced biological and biochemical analyses. Comparisons of all these multi-instrumental measurements between the two populations are performed at baseline and at 12 month follow-up, with multidisciplinary investigative approach. A mix of risk and predisposition factors should emerge combining the three groups of measures, in the two populations, along the two times of data collection.

Conditions

Interventions

TypeNameDescription
PROCEDUREFull AnalysisPopulation 1 receives all three groups of analyses:Clinical-metabolical analyses, Biological-biochemical analyses, and Biomechanical-functional analyses.
PROCEDUREPartial AnalysisPopulation 2 receives two groups of analyses:Clinical-metabolical analyses and Biological-biochemical analyses.

Timeline

Start date
2025-11-03
Primary completion
2027-03-15
Completion
2027-05-15
First posted
2025-06-13
Last updated
2026-01-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07021222. Inclusion in this directory is not an endorsement.